Amends TCA Title 4; Title 53 and Title 63.

Under this bill, if a patient informs a pharmacy that the patient identifies as an individual who is blind, visually impaired, or otherwise print disabled, then the pharmacist must dispense the patient's prescription with an accessible prescription label that: (1) Is appropriate to the disability and preference of the individual making the request through use of audible, large print, or Braille labels; (2) Conforms to the format specific best practices established by the United States access board; (3) Contains label information required by state and federal law, including cautions and warnings, and information available to sighted individuals reading the printed label; (4) Is usable for at least the duration of the prescription; (5) Does not incur additional cost to the patient; and (6) Is available to the patient in a timely manner comparable to other patients' wait time. This bill also requires a pharmacy to ensure that the prescription label as described above is compatible with the prescription reader if a reader is provided. This bill defines "prescription reader" as a device that is designed to audibly convey the information contained on the label of a prescription drug. For rulemaking purposes, this bill will take effect upon becoming law. For all other purposes, this bill will take effect January 1, 2023. ON MARCH 30, 2022, THE SENATE ADOPTED AMENDMENT #1 AND PASSED SENATE BILL 1859, AS AMENDED. AMENDMENT #1 adds a preamble and rewrites this bill to require the board of pharmacy to promulgate rules necessary to ensure that an individual who is blind, visually impaired, or otherwise print disabled has appropriate access to prescription labels, bag tags, and medical guides.